Pseudo-pseudo Meigs syndrome or Tjalma syndrome is characterized by increased CA-125 level, pleural effusion and ascites in systemic lupus erythematosus (SLE) patients without over tumor. The disorder is relatively rare and it has been reported usually in SLE patients with impaired renal functions. Herein, we present a case of a 47-year-old female patient who developed Tjalma syndrome after administration of leflunomide for rheumatoid arthritis. Surprisingly renal functions of our patient were found in normal limits. This is the first case of Tjalma syndrome that is developed in normal renal functions and the probable role of leflunomide therapy is discussed.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00296-009-1190-2DOI Listing

Publication Analysis

Top Keywords

tjalma syndrome
12
renal functions
12
pseudo-pseudo meigs
8
meigs syndrome
8
syndrome developed
8
leflunomide therapy
8
sle patients
8
syndrome
5
developed leflunomide
4
therapy pseudo-pseudo
4

Similar Publications

Pseudo-pseudo Meigs' syndrome (PPMS), also known as Tjalma syndrome, is an exceptionally rare condition marked by pleural effusion, ascites, and elevated CA-125 levels, usually in the context of systemic lupus erythematosus (SLE) without any associated ovarian tumors. We report the case of a 40-year-old woman who presented with a four-month history of fatigue, nausea, weight loss, abdominal pain, and pleural effusion. Initial diagnostic workup revealed ascites, elevated CA-125 levels, and pleural effusions, with no evidence of malignancy.

View Article and Find Full Text PDF
Article Synopsis
  • Tjalma's syndrome is a benign condition found in patients with systemic lupus erythematosus, characterized by ascites, pleural effusion, and elevated CA-125 levels.
  • Case reports are limited, making this case particularly significant; the patient presented with skin issues, massive pleural effusion, and elevated CA-125 but was ultimately diagnosed with bullous systemic lupus erythematosus after ruling out cancer.
  • The hope is that sharing this case will enhance understanding of Tjalma's syndrome, helping to reduce unnecessary anxiety and medical procedures for similar patients.
View Article and Find Full Text PDF
Article Synopsis
  • The condition known as pseudo-pseudo Meigs' syndrome (PPMS) occurs in systemic lupus erythematosus (SLE) patients and is characterized by ascites, pleural effusion, and elevated CA-125 levels without any ovarian cancer.
  • A 33-year-old female patient was diagnosed with SLE after experiencing persistent pleural effusion and new onset massive ascites alongside increased CA-125 levels, which led to a renal biopsy revealing class-V lupus nephritis.
  • Treatment with immunosuppressants resulted in significant improvement of SLE symptoms and PPMS components, including the ascites and pleural effusion, without the necessity for diuretics, highlighting the importance of thorough evaluation and treatment in such
View Article and Find Full Text PDF

Elevated CA-125 levels, polyserous effusions (such as pleural effusion, ascites, etc.) in young women with systemic lupus erythematosus (SLE) may signal pseudo-pseudo Meigs' syndrome (PPMS), after excluding other causes. We describe a 32-year-old SLE patient with recurrent bilateral pleural effusions and unexplained hypercalcemia for 10 months.

View Article and Find Full Text PDF
Article Synopsis
  • Pseudo-pseudo Meigs' syndrome (PPMS), or Tjalma syndrome, is a rare condition linked to systemic lupus erythematosus (SLE) that presents with ascites, pleural effusion, and elevated CA-125 levels.
  • A case study of a 74-year-old woman with a history of SLE exhibited these symptoms without any signs of tumors or malignancies on imaging, supporting the diagnosis of PPMS.
  • It's important to consider PPMS when patients show this specific combination of symptoms, as early diagnosis can improve treatment approaches and research outcomes.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!